Literature DB >> 3768896

1H-n.m.r. analysis of glycolipids possessing mono- and multi-meric X and Y haptens: characterization of two novel extended Y structures from human adenocarcinoma.

S B Levery, E D Nudelman, N H Andersen, S Hakomori.   

Abstract

Analysis of glycolipids having repeating core-structures of type 2 chains ([Gal beta 1----4GlcNAc beta 1----3]nGal beta 1----4Glc beta 1----1Cer) by 1- and 2-dimensional high resolution 1H-n.m.r. spectroscopy shows that fucosylation alpha 1----3 to GlcNAc with or without fucosylation alpha 1----2 to Gal produces predictable chemical shifts of anomeric protons and systematic, glycosylation-induced shift changes. These effects were analyzed for a series of glycolipids of known structure bearing mono- and multimeric X [Gal beta 1----4(Fuc alpha 1----3)GlcNAc beta 1----3] and Y [Fuc alpha 1----2Gal beta 1----4-(Fuc alpha 1----3)GlcNAc beta 1----3] determinants, and were subsequently used to elucidate the primary saccharide structure of two novel glycolipids isolated from human liver adenocarcinoma. They are proposed to be Y determinants carried on a norhexaosylceramide core, with the following structures: (Formula: see text).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768896     DOI: 10.1016/s0008-6215(00)90351-3

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  10 in total

1.  Identification of an intestinal neutral glycosphingolipid as a phenotype-specific receptor for the K88ad fimbrial adhesin of Escherichia coli.

Authors:  P A Grange; A K Erickson; S B Levery; D H Francis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Two novel isoneolacto-undecaglycosylceramides carrying Galalpha1-->3Lewis(x) on the 6-linked antenna and N-acetylneuraminic acidalpha2-->3 or Galactose alpha1-->3 on the 3-linked antenna, expressed in porcine kidney.

Authors:  D Bouhours; J Liaigre; J Lemoine; F Mayer-Posner; J F Bouhours
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

3.  Structural and immunochemical identification of Leb glycolipids in the plasma of a group O Le(a-b-) secretor.

Authors:  S M Henry; P A Jovall; S Ghardashkhani; M L Gustavsson; B E Samuelsson
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

4.  Evaluation of receptor binding specificity of Escherichia coli K88 (F4) fimbrial adhesin variants using porcine serum transferrin and glycosphingolipids as model receptors.

Authors:  Philippe A Grange; Michèle A Mouricout; Steven B Levery; David H Francis; Alan K Erickson
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Structural and immunochemical identification of Le(a), Le(b), H type 1, and related glycolipids in small intestinal mucosa of a group O Le(a-b-) nonsecretor.

Authors:  S Henry; P A Jovall; S Ghardashkhani; A Elmgren; T Martinsson; G Larson; B Samuelsson
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

6.  A novel glycosphingolipid expressed in pig kidney: Gal alpha 1-3Lewis(x) hexaglycosylceramide.

Authors:  D Bouhours; J Liaigre; J Naulet; D Maume; J F Bouhours
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

7.  Blood group type glycosphingolipids of human kidneys. Structural characterization of extended globo-series compounds.

Authors:  J Holgersson; P A Jovall; B E Samuelsson; M E Breimer
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

8.  Structural characterization of blood group A glycosphingolipids recognized by the antibody 3G9-A.

Authors:  J B Briggs; R Mandrell; B A Macher
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

9.  Blood group glycosphingolipid expression in kidney of an individual with the rare blood group A1 Le(a-b+) p phenotype: absence of blood group structures based on the globoseries.

Authors:  K Lindström; P A Jovall; S Ghardashkani; B E Samuelsson; M E Breimer
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

10.  Total synthesis of glycononaosyl ceramide with a sialyl dimeric Le(x)-sequence.

Authors:  M Iida; A Endo; S Fujita; M Numata; K Suzuki; S Nunomura; T Ogawa
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.